us-gaap |
Additional Paid in Capital |
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. |
View
|
us-gaap |
Adjustment of Warrants Granted for Services |
Adjustment for noncash service expenses paid for by granting of warrants. |
View
|
us-gaap |
Adjustments to Additional Paid in Capital, Other |
Amount of other increase (decrease) in additional paid in capital (APIC). |
View
|
us-gaap |
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition |
Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. |
View
|
us-gaap |
Adjustments to Additional Paid in Capital, Warrant Issued |
Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. |
View
|
us-gaap |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
View
|
us-gaap |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
View
|
us-gaap |
Increase (Decrease) in Accounts Payable and Accrued Liabilities |
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
View
|
us-gaap |
Increase (Decrease) in Deposit Assets |
The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits. |
View
|
us-gaap |
Increase (Decrease) in Other Current Assets |
Amount of increase (decrease) in current assets classified as other. |
View
|
us-gaap |
Net Cash Provided by (Used in) Investing Activities |
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
View
|
us-gaap |
Net Cash Provided by (Used in) Operating Activities |
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. |
View
|
us-gaap |
Research and Development Expense |
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. |
View
|
us-gaap |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. |
View
|
us-gaap |
Stockholders' Equity Attributable to Parent |
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. |
View
|
us-gaap |
Stock Issued During Period, Value, Issued for Services |
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent |
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent |
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). |
View
|
dei |
Entity Common Stock, Shares Outstanding |
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. |
View
|
dei |
Entity Public Float |
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. |
View
|
dei |
Entity Listing, Par Value Per Share |
The par value per share of security quoted in same currency as Trading currency. Example: '0.01'. |
View
|
us-gaap |
Accounts Payable and Accrued Liabilities, Current |
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
View
|
us-gaap |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. |
View
|
us-gaap |
Amortization |
The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. |
View
|
us-gaap |
Amortization of Intangible Assets |
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
View
|
us-gaap |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. |
View
|
us-gaap |
Assets |
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Assets, Current |
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Cash |
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
View
|
us-gaap |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
View
|
us-gaap |
Cash, FDIC Insured Amount |
The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. |
View
|
us-gaap |
Common Stock, Par or Stated Value Per Share |
Face amount or stated value per share of common stock. |
View
|
us-gaap |
Common Stock, Shares Authorized |
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Common Stock, Shares, Issued |
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. |
View
|
us-gaap |
Common Stock, Shares, Outstanding |
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. |
View
|
us-gaap |
Common Stock, Value, Issued |
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
View
|
us-gaap |
Deposits Assets, Current |
Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. |
View
|
us-gaap |
Depreciation |
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
View
|
us-gaap |
Earnings Per Share, Basic |
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. |
View
|
us-gaap |
Finite-Lived Intangible Assets, Accumulated Amortization |
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
View
|
us-gaap |
General and Administrative Expense |
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
View
|
us-gaap |
Impairment of Intangible Assets, Finite-lived |
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. |
View
|
us-gaap |
Increase (Decrease) in Other Current Liabilities |
Amount of increase (decrease) in current liabilities classified as other. |
View
|
us-gaap |
Inventory, Net |
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
View
|
us-gaap |
Issuance of Stock and Warrants for Services or Claims |
Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. |
View
|
us-gaap |
Liabilities |
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. |
View
|
us-gaap |
Liabilities and Equity |
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
View
|
us-gaap |
Liabilities, Current |
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
View
|
us-gaap |
Net Cash Provided by (Used in) Financing Activities |
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
View
|
us-gaap |
Net Income (Loss) Attributable to Parent |
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
View
|
us-gaap |
Operating Expenses |
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
View
|
us-gaap |
Operating Income (Loss) |
The net result for the period of deducting operating expenses from operating revenues. |
View
|
us-gaap |
Other Assets, Current |
Amount of current assets classified as other. |
View
|
us-gaap |
Other Liabilities, Current |
Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
View
|
us-gaap |
Payments to Acquire Property, Plant, and Equipment |
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
View
|
us-gaap |
Preferred Stock, Par or Stated Value Per Share |
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. |
View
|
us-gaap |
Preferred Stock, Shares Authorized |
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Preferred Stock, Shares Issued |
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. |
View
|
us-gaap |
Preferred Stock, Shares Outstanding |
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. |
View
|
us-gaap |
Proceeds from Issuance of Common Stock |
The cash inflow from the additional capital contribution to the entity. |
View
|
us-gaap |
Property, Plant and Equipment, Net |
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
View
|
us-gaap |
Retained Earnings (Accumulated Deficit) |
The cumulative amount of the reporting entity's undistributed earnings or deficit. |
View
|
us-gaap |
Share-based Payment Arrangement, Noncash Expense |
Amount of noncash expense for share-based payment arrangement. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
Gross number of share options (or share units) granted during the period. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
Number of options outstanding, including both vested and non-vested options. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. |
View
|
us-gaap |
Stock Issued |
The fair value of stock issued in noncash financing activities. |
View
|
us-gaap |
Stock Issued During Period, Value, New Issues |
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Diluted |
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Basic |
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
View
|
us-gaap |
Impairment of Long-Lived Assets to be Disposed of |
The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. |
View
|
us-gaap |
Increase (Decrease) in Inventories |
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
View
|
us-gaap |
Increase (Decrease) in Notes Payable, Current |
The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes. |
View
|
us-gaap |
Short-term Bank Loans and Notes Payable |
Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer. |
View
|
us-gaap |
Deferred Tax Assets, Operating Loss Carryforwards |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. |
View
|
us-gaap |
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. |
View
|
us-gaap |
Deferred Tax Assets, Valuation Allowance |
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Percent |
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent |
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. |
View
|
us-gaap |
Marketing and Advertising Expense |
The total expense recognized in the period for promotion, public relations, and brand or product advertising. |
View
|
us-gaap |
Nonoperating Income (Expense) |
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
View
|
us-gaap |
Operating Loss Carryforwards |
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. |
View
|
us-gaap |
Other General and Administrative Expense |
Amount of general and administrative expense classified as other. |
View
|
us-gaap |
Research and Development Expense (Excluding Acquired in Process Cost) |
The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. |
View
|
us-gaap |
Earnings Per Share, Diluted |
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. |
View
|
us-gaap |
Accounts Payable |
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
View
|
us-gaap |
Accrued Liabilities, Current |
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
View
|
us-gaap |
Gain (Loss) on Extinguishment of Debt |
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. |
View
|
us-gaap |
Other Income |
Amount of revenue and income classified as other. |
View
|
us-gaap |
Proceeds from Related Party Debt |
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
View
|
us-gaap |
Shares Issued, Value, Share-based Payment Arrangement, Forfeited |
Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
View
|
us-gaap |
APIC, Share-based Payment Arrangement, Increase for Cost Recognition |
Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
View
|
us-gaap |
Interest Expense, Other |
Amount of interest expense classified as other. |
View
|
us-gaap |
Other Nonoperating Expense |
Amount of expense related to nonoperating activities, classified as other. |
View
|